Literature DB >> 28579125

Prognostic Implications of Left Ventricular Global Longitudinal Strain in Predialysis and Dialysis Patients.

Liselotte C R Hensen1, Kathleen Goossens1, Victoria Delgado1, Joris I Rotmans2, J Wouter Jukema1, Jeroen J Bax3.   

Abstract

Chronic kidney disease (CKD) is a worldwide growing epidemic associated with an increased risk of cardiovascular morbidity and mortality. Left ventricular (LV) global longitudinal strain (GLS) is a measure of LV systolic function associated with prognosis in the general population. However, little is known about the association between LV GLS and survival in patients with CKD. The aim of the present study was to investigate the prognostic implications of LV GLS in predialysis and dialysis patients specifically. LV GLS was measured in a retrospective cohort of predialysis and dialysis patients (CKD stage 3b to 5) who underwent clinically indicated echocardiography between 2004 and 2015. Patients were divided into 4 groups according to quartiles of LV GLS: first quartile (LV GLS ≤10.6%, worst function), second quartile (LV GLS 10.7% to 15.1%), third quartile (LV GLS 15.2% to 17.8%), and fourth quartile (LV GLS ≥17.9%, best function). The primary end point was all-cause mortality. Of 304 patients (62 ± 14 years, 66% male), 65% were in predialysis and 35% in dialysis. During a median follow-up of 29 months (interquartile range 16 to 58 months), 34% of patients underwent renal transplantation and 36% died. Patients with LV GLS ≤10.6% showed significantly worse prognosis compared with the other groups (log-rank test, p <0.001). LV GLS ≤10.6% was significantly associated with increased risk of all-cause mortality (hazard ratio 2.18, 95% CI 1.17 to 4.06, p = 0.014) after correcting for age, gender, albumin levels, atrial fibrillation, and renal transplantation. In conclusion, in predialysis and dialysis patients, severely impaired LV GLS is independently associated with an increased risk of mortality.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28579125     DOI: 10.1016/j.amjcard.2017.04.054

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment.

Authors:  Navkaranbir S Bajaj; Amitoj Singh; Wunan Zhou; Ankur Gupta; Kana Fujikura; Christina Byrne; Hendrik J Harms; Michael T Osborne; Paco Bravo; Efstathia Andrikopolou; Sanjay Divakaran; Courtney F Bibbo; Jon Hainer; Hicham Skali; Viviany Taqueti; Michael Steigner; Sharmila Dorbala; David M Charytan; Sumanth D Prabhu; Ron Blankstein; Rahul C Deo; Scott D Solomon; Marcelo F Di Carli
Journal:  Circulation       Date:  2019-11-29       Impact factor: 29.690

2.  Defining Myocardial Abnormalities Across the Stages of Chronic Kidney Disease: A Cardiac Magnetic Resonance Imaging Study.

Authors:  Manvir K Hayer; Ashwin Radhakrishnan; Anna M Price; Boyang Liu; Shanat Baig; Christopher J Weston; Luca Biasiolli; Charles J Ferro; Jonathan N Townend; Richard P Steeds; Nicola C Edwards
Journal:  JACC Cardiovasc Imaging       Date:  2020-07-15

3.  Echocardiography-based pressure-volume loop assessment in the evaluation for the effects of indoxyl sulfate on cardiovascular function.

Authors:  Masaru Obokata; Koji Kurosawa; Hideki Ishida; Kyoko Ito; Tetsuya Ogawa; Yoshitaka Ando; Masahiko Kurabayashi; Kazuaki Negishi
Journal:  J Echocardiogr       Date:  2018-07-07

4.  Identification of cardiovascular abnormalities by multiparametric magnetic resonance imaging in end-stage renal disease patients with preserved left ventricular ejection fraction.

Authors:  Ling Lin; Qiuxia Xie; Mei Zheng; Xuhui Zhou; Ilona A Dekkers; Qian Tao; Hildo J Lamb
Journal:  Eur Radiol       Date:  2021-02-24       Impact factor: 5.315

5.  High-sensitive troponin T increase after hemodialysis is associated with left ventricular global longitudinal strain and ultrafiltration rate.

Authors:  Serkan Ünlü; Asife Şahinarslan; Burak Sezenöz; Orhan Mecit Uludağ; Gökhan Gökalp; Özden Seçkin; Selim Turgay Arınsoy; Özlem Gülbahar; Nuri Bülent Boyacı
Journal:  Cardiol J       Date:  2018-10-19       Impact factor: 2.737

Review 6.  Cardiovascular risk factors in children on dialysis: an update.

Authors:  Uwe Querfeld; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2018-10-31       Impact factor: 3.714

7.  Chronic kidney disease and cardiovascular mortality in patients with atrial fibrillation: European Society of Hypertension project - ESH A Fib.

Authors:  Vedran Premužić; Ranko Stevanović; Petra Radić; Massimo Salvetti; Martina Lovrić-Benčić; Ana Jelaković; Davor Miličić; Krunoslav Capak; Enrico Agabiti-Rosei; Bojan Jelaković
Journal:  Medicine (Baltimore)       Date:  2021-01-15       Impact factor: 1.817

8.  Global longitudinal strain by feature-tracking cardiovascular magnetic resonance imaging predicts mortality in patients with end-stage kidney disease.

Authors:  Alastair J Rankin; Luke Zhu; Kenneth Mangion; Elaine Rutherford; Keith A Gillis; Jennifer S Lees; Rosie Woodward; Rajan K Patel; Colin Berry; Giles Roditi; Patrick B Mark
Journal:  Clin Kidney J       Date:  2021-02-02

9.  Subclinical cardiac dysfunction in pediatric kidney transplant recipients identified by speckle-tracking echocardiography.

Authors:  Adrienn Bárczi; Bálint Károly Lakatos; Mónika Szilágyi; Éva Kis; Orsolya Cseprekál; Alexandra Fábián; Attila Kovács; Attila J Szabó; Béla Merkely; Paolo Salvi; György S Reusz
Journal:  Pediatr Nephrol       Date:  2022-02-15       Impact factor: 3.651

10.  Feature-tracking cardiac magnetic resonance left ventricular global longitudinal strain improves 6 months after kidney transplantation associated with reverse remodeling, not myocardial tissue characteristics.

Authors:  Maurício Fregonesi Barbosa; Mariana Moraes Contti; Luis Gustavo Modelli de Andrade; Alejandra Del Carmen Villanueva Mauricio; Sergio Marrone Ribeiro; Gilberto Szarf
Journal:  Int J Cardiovasc Imaging       Date:  2021-05-17       Impact factor: 2.357

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.